Tumor-stroma ratio(TSR) as a potential novel predictor of prognosis in digestive system cancers: A meta-analysis
Authors:
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 472, 64-68
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progressionCancer and Metastasis Reviews, 2011
- Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsiesEuropean Journal of Cancer, 2011
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsBritish Journal of Cancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progressionSeminars in Cell & Developmental Biology, 2010
- Antioxidant supplements for preventing gastrointestinal cancersCochrane Database of Systematic Reviews, 2008
- TGFβ in CancerCell, 2008
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002